Cre8tek’s Flamingo and Nationwide Insurance go live with Virtual Assistant


Published 06-NOV-2017 08:00 A.M.


3 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

Cre8tek (ASX:CR8), owner of high-tech, Artificial Intelligence company and Cognitive Virtual Assistant platform provider, Flamingo Customer Experience Inc. has announced the commencement of its post testing go-live phase with Nationwide Insurance using Flamingo’s Cognitive Virtual Assistant platform, ROSIE.

This news proved to be a significant catalyst for CR8’s share price as it surged from the previous day’s close of 6.9 cents to hit a mid-morning high of 8.4 cents, representing an increase of more than 20 per cent.

The past performance of this product is not and should not be taken as an indication of future performance. Caution should be exercised in assessing past performance. This product, like all other financial products, is subject to market forces and unpredictable events that may adversely affect future performance.

Nationwide Insurance is a US-based Fortune 100 company, and after the successful completion of a ‘soft-launch’, the group has now entered the next phase of ‘go-live’, where the platform is being used by Nationwide to interact with customers on an extended basis for their Guaranteed Retirement Income direct-to-customer product.

As a backdrop, CR8 acquired Flamingo Customer Experience Inc. in November 2016. The company is based in New York and Sydney, operating in the emerging Conversational Commerce field. Flamingo is an Enterprise SaaS company which provides a Cognitive Virtual Assistant (AI) platform designed for selling complex financial products online. The group’s cognitive Virtual Assistants are called ROSIE and MAGGIE.

Commenting on this recent development, Nationwide’s Innovation Lead, Scott Bair, said, “We are excited to see the impact that introducing Flamingo’s virtual assistant, ROSIE, has on the decision-making process for our customers who are considering Guaranteed Retirement Income from Nationwide.”

This deployment further strengthens the relationship with Nationwide, which has been a client of Flamingo’s since 2015.

Since bringing Nationwide on board as a client Flamingo has conducted a number of trials (four) of earlier versions of the platform across its various insurance products and in May 2016 a Master Services Agreement (MSA) was forged between the two parties, a very significant achievement for an early stage company.

Of course as Flamingo is an early stage company, investors should seek professional financial advice if considering this stock for their portfolio.

In January 2017, Flamingo signed a Statement of Work to design a Virtual Sales Assistant for Nationwide, and by August a Production Statement of Work related to the implementation of the Virtual Sales Assistant (now live) had been negotiated. The Production Statement of Work contract included a Monthly Recurring Revenue (MRR) component which has provided revenue visibility and predictability for the group.

Integral to the deployment was a program of highly rigorous security and data privacy audits, technology architecture reviews and these were successfully completed by Flamingo.

The MSA allows the company to conduct other Statements of Work and Flamingo is currently in active discussions related to potential deployments in multiple Nationwide business units.

Given the security and technology review work already conducted it is expected that future deployments will be substantially faster to implement. These high standards will also act as a considerable barrier to entry for other players or competitors trying to enter this market.

Flamingo also highlighted the fact that all current client implementations are progressing well, with management indicating it would be providing the market with further updates on progress with client deployments.

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free